Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome.

Perdigoto AL, Quandt Z, Anderson M, Herold KC.

Lancet Diabetes Endocrinol. 2019 Jun;7(6):421-423. doi: 10.1016/S2213-8587(19)30072-5. Epub 2019 Mar 15. No abstract available.

PMID:
30885563
2.

Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.

Perdigoto AL, Preston-Hurlburt P, Clark P, Long SA, Linsley PS, Harris KM, Gitelman SE, Greenbaum CJ, Gottlieb PA, Hagopian W, Woodwyk A, Dziura J, Herold KC; Immune Tolerance Network.

Diabetologia. 2019 Apr;62(4):655-664. doi: 10.1007/s00125-018-4786-9. Epub 2018 Dec 19.

PMID:
30569273
3.

Identification and Analysis of Islet Antigen-Specific CD8+ T Cells with T Cell Libraries.

Ogura H, Preston-Hurlburt P, Perdigoto AL, Amodio M, Krishnaswamy S, Clark P, Yu H, Egli D, Fouts A, Steck AK, Herold KC.

J Immunol. 2018 Sep 15;201(6):1662-1670. doi: 10.4049/jimmunol.1800267. Epub 2018 Aug 6.

PMID:
30082321
4.

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.

Stamatouli AM, Quandt Z, Perdigoto AL, Clark PL, Kluger H, Weiss SA, Gettinger S, Sznol M, Young A, Rushakoff R, Lee J, Bluestone JA, Anderson M, Herold KC.

Diabetes. 2018 Aug;67(8):1471-1480. doi: 10.2337/dbi18-0002. Epub 2018 Jun 24. Review.

5.

Have we pushed the needle for treatment of Type 1 diabetes?

Naushad N, Perdigoto AL, Rui J, Herold KC.

Curr Opin Immunol. 2017 Dec;49:44-50. doi: 10.1016/j.coi.2017.09.004. Epub 2017 Oct 6. Review.

6.

β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice.

Rui J, Deng S, Arazi A, Perdigoto AL, Liu Z, Herold KC.

Cell Metab. 2017 Mar 7;25(3):727-738. doi: 10.1016/j.cmet.2017.01.005. Epub 2017 Feb 9.

7.

Inducing and Administering Tregs to Treat Human Disease.

Perdigoto AL, Chatenoud L, Bluestone JA, Herold KC.

Front Immunol. 2016 Jan 22;6:654. doi: 10.3389/fimmu.2015.00654. eCollection 2015. Review.

8.

miR-153 regulates SNAP-25, synaptic transmission, and neuronal development.

Wei C, Thatcher EJ, Olena AF, Cha DJ, Perdigoto AL, Marshall AF, Carter BD, Broadie K, Patton JG.

PLoS One. 2013;8(2):e57080. doi: 10.1371/journal.pone.0057080. Epub 2013 Feb 25.

9.

A novel role for PTEN in the inhibition of neurite outgrowth by myelin-associated glycoprotein in cortical neurons.

Perdigoto AL, Chaudhry N, Barnes GN, Filbin MT, Carter BD.

Mol Cell Neurosci. 2011 Jan;46(1):235-44. doi: 10.1016/j.mcn.2010.09.006. Epub 2010 Sep 30.

10.

Junctional adhesion molecule-A is required for hematogenous dissemination of reovirus.

Antar AA, Konopka JL, Campbell JA, Henry RA, Perdigoto AL, Carter BD, Pozzi A, Abel TW, Dermody TS.

Cell Host Microbe. 2009 Jan 22;5(1):59-71. doi: 10.1016/j.chom.2008.12.001.

11.

Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry.

Madani N, Hubicki AM, Perdigoto AL, Springer M, Sodroski J.

J Virol. 2007 Jan;81(2):532-8. Epub 2006 Aug 30.

12.

Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells.

McLaughlin JN, Mazzoni MR, Cleator JH, Earls L, Perdigoto AL, Brooks JD, Muldowney JA 3rd, Vaughan DE, Hamm HE.

J Biol Chem. 2005 Jun 10;280(23):22172-80. Epub 2005 Apr 7.

13.

Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155.

Madani N, Perdigoto AL, Srinivasan K, Cox JM, Chruma JJ, LaLonde J, Head M, Smith AB 3rd, Sodroski JG.

J Virol. 2004 Apr;78(7):3742-52.

14.

Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection.

Li J, Tong S, Lee HB, Perdigoto AL, Spangenberg HC, Wands JR.

J Virol. 2004 Feb;78(4):1873-81.

Supplemental Content

Loading ...
Support Center